Antihistamines and survival from ovarian cancer: A population-based cohort study and in vitro cell viability study

Christian Dehlendorff; Freija Verdoodt; Marja Jaattela; Robert Strauss; Anton Pottegard; Jesper Hallas; Susanne K. Kjaer; Søren Friis

Antihistamines and survival from ovarian cancer: A population-based cohort study and in vitro cell viability study

Christian Dehlendorff, Freija Verdoodt, Marja Jaattela, Robert Strauss, Anton Pottegard, Jesper Hallas, Susanne K. Kjaer, Søren Friis

Institut for Klinisk Medicin

Originalsprog	Engelsk
Tidsskrift	Pharmacoepidemiology and Drug Safety
Vol/bind	28
Udgave nummer	S2
Sider (fra-til)	125
Antal sider	1
ISSN	1053-8569
Status	Udgivet - 2019

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

https://onlinelibrary.wiley.com/toc/10991557/2019/28/S2

Citationsformater

@article{28952af5181242449123b632b8349190,

title = "Antihistamines and survival from ovarian cancer: A population-based cohort study and in vitro cell viability study",

author = "Christian Dehlendorff and Freija Verdoodt and Marja Jaattela and Robert Strauss and Anton Pottegard and Jesper Hallas and Kjaer, {Susanne K.} and S{\o}ren Friis",

year = "2019",

language = "English",

volume = "28",

pages = "125",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "JohnWiley & Sons Ltd",

number = "S2",

}

TY - ABST

T1 - Antihistamines and survival from ovarian cancer: A population-based cohort study and in vitro cell viability study

AU - Dehlendorff, Christian

AU - Verdoodt, Freija

AU - Jaattela, Marja

AU - Strauss, Robert

AU - Pottegard, Anton

AU - Hallas, Jesper

AU - Kjaer, Susanne K.

AU - Friis, Søren

PY - 2019

Y1 - 2019

M3 - Conference abstract in journal

SN - 1053-8569

VL - 28

SP - 125

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - S2

ER -